Aker BioMarine ASA Navne-Aksjer NK 6
- BID
9.5
- ASK
9.78
- 977 Units511 Units
- 07/21, 18:51:40 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
46.59%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.23 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 9.5 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 06:34:53 PM | |
| DAILY VOLUME (UNITS) | 50 | |
| DAILY HIGH / LOW | 9.61 | 9.43 |
| PREV. DAY'S PRICE | 9.47 | (07/20) |
| CHANGE DAY BEFORE | +0.03 | 0.32 % |
| 52 WEEK HIGH / LOW | 10.36 (05/29) | 6.28 (08/13) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.10 | -0.30 | -0.23 | 0.06 | 0.27 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | 155.03 | 34.64 |
PRICE - BOOK RATIO | 1.08 | 2.98 | - | - | - |
PRICE - SALES RATIO | 1.14 | 2.75 | - | - | - |
PRICE - CASH FLOW RATIO | 8.05 | 44.84 | - | - | - |
Master Data
| WKN | A2P701 |
| ISIN | NO0010886625 |
| SYMBOL | 1PG |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | AKER BIOMARINE ASA NK 6 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 13.96 % | 7.37 % | 0.53 % | 16.48 % | 46.59 % | 190.05 % | 87.15 % | 20.48 % |
| HIGH | 9.54 | 9.54 | 10.36 | 10.36 | 10.36 | 10.36 | 10.36 | 10.36 |
| LOW | 8.27 | 8.27 | 8.27 | 7.77 | 6.28 | 2.98 | 2.64 | 7.77 |
Dividende
pro Aktie
AKER BIOMARINE ASA NK 6 does not deliver dividend information
Company profile
Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. It operates through the Ingredients and Brands segments. The Ingredients segment includes offshore harvesting and production activities, logistical operations, and the onshore manufacturing and sale of krill oil products globally to distributors and feed producers. The Brands segment relates to the group legal entities Lang Pharma Nutrition LLC, Epion Brands LLC , and the holding company New Ride LLC. The company was founded in 2006 and is headquartered in Lysaker, Norway.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.